According to reports from the Wall Street Journal and other sources, Baxter has upped its price offering from $144 per share offered in July to around $150 per share, which would result in approximately $10 billion for Hill-Rom. Baxter’s previous offer would have totaled about $9.6 billion.
Reportedly, these discussions follow a bid from Baxter in July worth $144 per share that Hill-Rom rebuffed. Hill-Rom stock rose at the news of that bid and have remained elevated. The stock closed Friday at $132.90.
The latest news has sent Hill-Rom’s stock up by about 10% to just over $147.
Healthcare Purchasing News reported recently that besides the Hill-Rom portfolio of beds and infection prevention products from its acquisition of Welch-Allyn and a nurse call platform from Voalte, the company launched its Hill-Rom Extended Care Solution, a new, connected remote vital signs monitoring device that allows clinicians to shift care closer to home.
